On the contrary, the FJX1 expression in cancer tissues was lower significantly, compared with normal tissues, including the kidney chromophobe (KICH), acute myeloid leukemia (LAML), lung adenocarcinoma (LUAD), prostate adenocarcinoma (PRAD), and skin cutaneous melanoma (SKCM) (Figure 1A). This evidence concerns the gene FJX1 and acute myeloid leukemia.